Skip to main content
Skip to content
Case File
efta-01522008DOJ Data Set 10Other

EFTA01522008

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522008
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL ACCT For the Period 3/1/14 to 3 1/14 Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation US Large Cap Equity 489.081.56 472.35396 (16.727.60) 9% US Small/Mid Cap Equity 14265.00 6270.00 (7995.00) 1% Non-US Equity 172.57 0.00 (172.57) Preferred Stocks 445.348 00 448.600 00 3.252.00 9% Concentrated 8 Other Equity 167.266 50 168.076 50 810.00 3% Total Value $1,116,133.63 $1,095,300.46 ($20,833.17) 22% Nlark et Value/Cost Current Period Value Asset Categories us Smell/Mid Cap Equity Concorrtratod a OOnr US Lupe Cap Equity Market Value 1,095,300.46 Tar. Cost 1.034A70 01 Unrealized Gain aos'a 60,830 45 Pretested Stocks Estimated Annual Income 50.258 57 6 065 77 Equity as a percentage of your portfolio - 22 % Accrued Di. deeds Yield 4 57% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA J.P.Morgan 82.95 95.000 7.860.25 11403.30 (3.523.05) 95.00 1.21 % Page 5 of 24 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049468 SDNY_GM_00318666 EFTA01522008

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.